Symptoms are not random chance—they have a real link to biological drivers of the disease and understanding them is important, said Ruben Mesa, MD, director of UT Health San Antonio MD Anderson Cancer Center.
Symptoms are not random chance—they have a real link to biological drivers of the disease and understanding them is important, said Ruben Mesa, MD, director of UT Health San Antonio MD Anderson Cancer Center.
Transcript
Your team created a quality of life model for patients with myeloproliferative neoplasms—ideally how would this model be used in practice or in clinical trials?
The purpose of the model is to really try to better understand the drivers of quality of life for patients, I think further validate and reinforce the importance of the improvement in symptoms as an important end point in clinical trials. We are also modeling that along with our efforts to better understand the biology behind the symptoms.
The symptoms in these diseases are not just random chance, you know, nor are they just psychological. They have a real link to biological drivers in the disease: increase inflammatory markers, increase in IL-8 [interleukin 8], increase in IL-8 have been associated with a decrease in survival. So, we think that they are important biological clues and trying to bring that additional sort of scientific rigor to better understand.
We're even learning that not all symptoms are really interchangeable. You know, there's certain symptoms that are clearly associated with progression, such as bone pain and inadvertent weight loss. There's others that are more multifactorial but might be present throughout, such as fatigue. So, we're learning a lot of the granular details of how to really interpret symptoms and use them just like we might look at a hemoglobin or a white cell count.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More